China Diagnostic Platform R&D and Manufacturing Base ProjectSigning and Settling in the Industrial ParkAdditional Investment, Deepened LayoutFortune Global 500 Companies Once Again Invest "Real Money"A Vote of Confidence in Suzhou Industrial Park
Wu Qingwen, Member of the Standing Committee of the Municipal Party Committee and Secretary of the Party Working Committee of the Industrial Park, and Liu Hua, Member of the Party Working Committee and Deputy Director of the Administrative Committee of the Industrial Park, attended the signing ceremony. 
Fortune Global 500: Danaher Corporation (USA)A Global Leader in Science and Technology Innovation InvestmentThe Group’s business portfolio spans life sciences, diagnostics, environmental and water solutions, and dental.，Its subsidiary, Beckman Coulter, established its first factory in the park as early as 1997., has grown into one of the strongest manufacturers globally in the fields of instrument equipment, reagents, software development and manufacturing for experimental medicine, with products sold in over 130 countries and a global network for technical support and after-sales service.
Danaher CorporationInvesting Hundreds of Millions of US DollarsEstablished within the parkChina Diagnostic Platform R&D and Manufacturing Base ProjectUnder Danaher CorporationBeckman Coulter Diagnostics,RadiometerJoint Operation by Four CompaniesCommitted to Building Rapid Diagnostic Localization SolutionsProtocolExpected to be put into use in 2023
This project is engaged in the R&D, production, and sales of rapid diagnostic instruments and reagents. It plans to establish regional headquarters and R&D center functions, further expanding and strengthening Danaher’s diagnostic platform capabilities in manufacturing, research and development, and customer support. Upon reaching full production capacity, it will have an annual output of 4 million boxes of rapid diagnostic reagents and 2,500 diagnostic instruments.
It is reported that construction of the Phase I plant, covering an area of 37,000 square meters, will commence by the end of this year.
Choosing the Park Out of TrustPeng Yang, President of Danaher Corporation's China Region, statedThe park boasts a strong talent pool and comprehensive infrastructure.Can significantly promote the development of corporate businessOur goal is to provide innovative, localized solutions that address unmet market needs. Establishing a multidisciplinary manufacturing and R&D hub within the industrial park will help us meet these demands. 
Danaher will also be based at this facilityBuildIntegrated Diagnostic Platform Customer Experience CenterShowcase Solutions for Different Medical ScenariosEmpowering Healthcare Professionals in Chinaand the Capacity Building of Hospital AdministratorsSupporting the Realization of the Healthy China Goals
Additionally Danaher Corporation has two more projects.
It has also been decided to establish a presence in the industrial park.
Cepheid Rapid Molecular Diagnostics ProjectCepheid, founded in 1996, is a leading molecular diagnostics company dedicated to the development, manufacturing, and sales of precise and user-friendly molecular diagnostic systems and assays for automated microbial genetic testing and genetic disease testing. Its products are professionally applied in the fields of infectious disease and cancer prevention and control. In 2016, Cepheid was acquired by the Danaher Diagnostics Platform.
Cepheid has confirmed the establishment of a new manufacturing facility in the industrial park, with a registered capital of USD 10 million. Initially, it will lease premises in the Bio-Industrial Park, and in the future, it will be integrated into the Danaher Diagnostics Platform Base project. There are also plans to establish a China R&D center. The company’s revenue is projected to reach approximately USD 130 million in 2025, with around 150 employees; by 2028, revenue is expected to reach approximately USD 240 million, with around 330 employees.Leica Microsystems ProjectLeica Microsystems is a specialized manufacturer in the field of global microscopy and analytical science instrumentation, primarily engaged in the research, development, and production of professional scientific instruments such as research-grade microscopes for microstructural and nanostructural analysis. In 2005, Leica Microsystems was acquired by the U.S.-based Danaher Corporation.In May 2019, Leica Microsystems established the China SMART Innovation Center (in the form of a branch company) within the park. In June 2020, it was converted into an independent legal entity with a registered capital of USD 6 million, and there are plans for additional investment in the future.This project focuses on the life sciences and industrial application sectors, developing cutting-edge products for the Chinese and global markets while accumulating related patents. The project adopts an OEM partnership model for production. Upon reaching full production capacity, annual sales are projected to reach USD 45 million, with a dedicated R&D team of 60 personnel.The Park Actively Creates a World-Class Business EnvironmentPromote Industrial Agglomeration and Transformation and UpgradingAttracting an increasing number of multinational corporate headquartersEstablishment of Shared Service Center and R&D Production BaseCurrently, the park is home to nearly 100 headquarters enterprises recognized at various levels.The number of headquarters enterprises accounts for nearly 20% of the province's total and nearly 30% of the city's total, ranking first in both the province and the city.。In the first half of this year, the industrial park added new foreign-funded projects117 items, complete the registration of foreign-funded enterprises$2.051 billion, year-on-year growth146.2%; Foreign capital received$1.28 billion, year-on-year increase196%。In the future,The park will continue Embrace the World with Open Arms Unswervingly Pursue the Path of High-Quality Development
| 
